Log in
Enquire now
‌

US Patent 10166200 Buffered oxygen therapeutics

Patent 10166200 was granted and assigned to NuvOx Pharma on January, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Patent Applicant
NuvOx Pharma
NuvOx Pharma
1
Current Assignee
NuvOx Pharma
NuvOx Pharma
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
101662001
Patent Inventor Names
Evan C. Unger1
Edmund R. Marinelli1
Date of Patent
January 1, 2019
1
Patent Application Number
156174921
Date Filed
June 8, 2017
1
Patent Primary Examiner
‌
James D. Anderson
1
Patent abstract

An oxygen therapeutic composition, which includes a perfluorocarbon material having a boiling point of about 4 degrees Celsius to about 60 degrees Celsius, a lipid; a viscosity modifier; a buffer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10166200 Buffered oxygen therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.